p38MAPK and ERK promote nitric oxide production in cultured human retinal pigmented epithelial cells induced by high concentration glucose

Nitric Oxide - Biology and Chemistry

Volumn 20, Issue 1, 2009, Pages 9-15

  Yuan, Zhilan ^a   Feng, Weiyan ^a   Hong, Jin ^a   Zheng, Qi ^a   Shuai, Jie ^a   Ge, Yingbin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

High glucose; iNOS; MAPK; Nitric oxide (NO); Nitrotyrosine; Retinal pigment epithelial (RPE) cells

Indexed keywords

3 NITROTYROSINE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GLUCOSE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UO 126;

ARTICLE; CELL CULTURE; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; OXIDATIVE STRESS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; WESTERN BLOTTING;

BIOLOGICAL MARKERS; CELL LINE; DIABETIC RETINOPATHY; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUCOSE; HUMANS; L-LACTATE DEHYDROGENASE; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RETINAL PIGMENT EPITHELIUM; SUPEROXIDE DISMUTASE; TYROSINE;

EID: 55549142152     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2008.09.001     Document Type: Article

References (54)

1. Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 67 (2005) 3-21
2. Gugliucci A. Glycation as the glucose link to diabetic complications. J. Am. Osteopath. Assoc. 100 (2000) 621-634
3. Kim Y.S., Kim B.C., Song C.Y., Hong H.K., Moon K.C., and Lee H.S. Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta. J. Lab. Clin. Med. 138 (2001) 59-68
4. Li J.H., Huang X.R., Zhu H.J., Oldfield M., Cooper M., Truong L.D., Johnson R.J., and Lan H.Y. Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease. FASEB J. 18 (2004) 176-178
5. Roy S., Sato T., Paryani G., and Kao R. Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes 52 (2003) 1229-1234
6. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54 (2005) 1615-1625
7. Ceriello A., Mercuri F., Quagliaro L., Assaloni R., Motz E., Tonutti L., and Taboga C. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 44 (2001) 834-838
8. Schmidt M., Giessl A., Laufs T., Hankeln T., Wolfrum U., and Burmester T. How does the eye breathe? Evidence for neuroglobin-mediated oxygen supply in the mammalian retina. J. Biol. Chem. 278 (2003) 1932-1935
9. Kowluru R.A., Kern T.S., and Engerman R.L. Abnormalities of retinal metabolism in diabetes or experimental galactosemia: IV. Antioxidant defense system. Free Radic. Biol. Med. 22 (1996) 587-592
10. Kowluru R.A., Tang J., and Kern T.S. Abnormalities of retinal metabolism in diabetes and experimental galactosemia: VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50 (2001) 1938-1942
11. Kowluru R.A. Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid. Redox Signal 7 (2005) 1581-1587
12. Obrosova I.G., and Julius U.A. Role for poly (ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy. Curr. Vasc. Pharmacol. 3 (2005) 267-283
13. Du X., Matsumura T., Edelstein D., Rossetti L., Zsengeller Z., Szabo C., and Brownlee M. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J. Clin. Invest. 112 (2003) 1049-1057
14. Inoguchi T., Li P., Umeda F., Yu H.Y., Kakimoto M., Imamura M., Aoki T., Etoh T., Hashimoto T., Naruse M., Sano H., Ustumi H., and Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAPDH oxidase in cultured vascular cells. Diabetes 49 (2000) 1939-1945
15. Loske C., Neumann A., Cunningham A.M., Nichol K., Schinzel R., Riederer P., and Munch G. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J. Neural Transm. 105 (1998) 1005-1015
16. Beltran B., Mathur A., Duchen M.R., Erusalimsky J.D., and Moncada S. The effect of nitric oxide on cell respiration: a key to understanding its role in cell survival or death. Proc. Natl. Acad. Sci. USA 97 (2000) 14602-14607
17. Moncada S., and Erusalimsky J.D. Does nitric oxide modulate mitochondrial energy generation and apoptosis?. Nat. Rev. Mol. Cell Biol. 3 (2002) 214-220
18. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357 Pt. 3 (2001) 593-615
19. Balligand J.L., and Cannon P.J. Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 1846-1858
20. Ellis E.A., Guberski D.L., Hutson B., and Grant M.B. Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. Nitric oxide 6 (2002) 295-304
21. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6 (1992) 3051-3064
22. Ceriello A., Quagliaro L., D'Amico M., Di Filippo C., Marfella R., Nappo F., Berrino L., Rossi F., and Giugliano D. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 51 (2002) 1076-1082
23. Bhat N.R., Zhang P., Lee J.C., and Hogan E.L. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18 (1998) 1633-1641
24. Yokoyama T., Yamane K., Minamoto A., Tsukamoto H., Yamashita H., Izumi S., Hoppe G., Sears J.E., and Mishima H.K. High glucose concentration induces elevated expression of anti-oxidant and proteolytic enzymes in cultured human retinal pigment epithelial cells. Exp. Eye Res. 83 (2006) 602-609
25. Rodriguez A.I., Pereira-Flores K., Hernández-Salinas R., Boric M.P., and Velarde V. High glucose increases B1-kinin receptor expression and signaling in endothelial cells. Biochem. Biophys. Res. Commun. 345 (2006) 652-659
26. Ballinger S.W., Van Houten B., Jin G.F., Conklin C.A., and Godley B.F. Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells. Exp. Eye Res. 68 (1999) 765-772
27. Jiao H., and Zhao B. Cytotoxic effect of peroxisome proliferators fenofibrate on human HepG2 hepatoma cell line and relevant mechanisms. Toxicol. Appl. Pharmacol. 185 (2002) 172-179
28. Liu S.X., Athar M., Lippai I., Waldren C., and Hei T.K. Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc. Natl. Acad. Sci. USA 98 (2001) 1643-1648
29. Ukeda H., Kawana D., Maeda S., and Sawamura M. Spectrophotometric assay for superoxide dismutase based on the reduction of highly water-soluble tetrazolium salts by xanthine-xanthine oxidase. Biosci. Biotechnol. Biochem. 63 (1999) 485-488
30. Kim S.H., Johnson V.J., and Sharma R.P. Mercury inhibits nitric oxide production but activates proinflammatory cytokine expression in murine macrophage: differential modulation of NF-κB and p38 MAPK signaling pathways. Nitric Oxide 7 (2002) 67-74
31. + when the Griess reaction is used to assay for nitrite. Anal. Biochem. 224 (1995) 502-508
32. Qu L.N., Yang T.B., Yuan Y.H., Zhong P., Yang B., and Zhao H. A novel competitive ELISA for both free and protein-bound nitrotyrosine. Hybrid. Hybridomics 22 (2003) 401-406
33. Huie R.E., and Padmaja S. The reaction of nitric oxide with superoxide. Free Radic. Res. Commun. (1993) 195-199
34. Beckman J.S., Chen J., Ischiropoulos H., and Crow J.P. Oxidative chemistry of peroxynitrite. Methods Enzymol. 233 (1994) 229-240
35. Radi R., Peluffo G., Alvarez N.M., Naviliat M., and Cayota A. Unraveling peroxynitrite formation in biological systems. Free Radic. Biol. Med. 30 (2001) 463-488
36. Ferdinandy P., and Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br. J. Pharmacol. 138 (2003) 532-543
37. Di Mario U., and Pugliese G. 15th Golgi lecture: from hyperglycaemia to the dysregulation of vascular remodelling in diabetes. Diabetologia 44 (2001) 674-692
38. Pricci F., Leto G., Amadio L., Iacobini C., Cordone S., Catalano S., Zicari A., Sorcini M., Dimario U., and Pugliese G. Oxidative stress in diabetes-induced endothelial dysfunction involvement of nitric oxide and protein kinase C. Free Radic. Biol. Med. 35 (2003) 683-694
39. Kamata H., and Hirata H. Redox regulation of cellular signalling. Cell. Signal. 11 (1999) 1-14
40. 2. Role in cell survival following oxidant injury. J. Biol. Chem. 271 (1996) 4138-4142
41. 2-terminal kinase). Eur. J. Biochem. 244 (1997) 587-595
42. Clerk A., Fuller S.J., Michael A., and Sugden P.H. Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogenactivated protein kinases) in perfused rat hearts by oxidative and other stresses. J. Biol. Chem. 273 (1998) 7228-7234
43. Klotz L.O., Pellieux C., Briviba K., Pierlot C., Aubry J.M., and Sies H. Mitogen-activated protein kinase (p38-, JNK-, ERK-) activation pattern induced by extracellular and intracellular singlet oxygen and UVA. Eur. J. Biochem. 260 (1999) 917-922
44. Cai L. Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy. Free Radic. Biol. Med. 41 (2006) 851-861
45. Jackson G., Owsley C., and Curcio C. Photoreceptor degeneration and dysfunction in aging and age-related maculopathy. Ageing Res. Rev. 1 (2002) 381-396
46. Zarbin M. Age-related macular degeneration: review of pathogenesis. Eur. J. Ophthalmol. 8 (1998) 199-206
47. Kennedy C.J., Rakoczy P.E., and Constable I.J. Lipofuscin of the retinal pigment epithelium: a review. Eye 9 (1995) 763-771
48. El-Remessy A.B., Behzadian M.A., Abou-Mohamed G., Franklin T., Caldwell R.W., and Caldwell R.B. Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am. J. Pathol. 162 (2003) 1995-2004
49. Ambs S., Merriam W.G., Bennett W.P., Felley-Bosco E., Ogunfusika M.O., Oser S.M., Klein S., Shields P.G., Billiar T.R., and Harris C.C. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 58 (1998) 334-341
50. Hoeldtke R.D., Bryner K.D., McNeill D.R., Hobbs G.R., Riggs J.E., Warehime S.S., Christie I., Ganser G., and Van Dyke K. Nitrosative stress, uric acid, and peripheral nerve function in early type 1 diabetes. Diabetes 51 (2002) 2817-2825
51. Inoue M., Itoh H., Ueda M., Naruko T., Kojima A., Komatsu R., Doi K., Ogawa Y., Tamura N., Takaya K., Igaki T., Yamashita J., Chun T.H., Masatsugu K., Becker A.E., and Nakao K. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 98 (1998) 2108-2116
52. Duh E., and Aiello L.P. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 48 (1999) 1899-1906
53. Celletti F.L., Waugh J.M., Amabile P.G., Brendolan A., Hilfiker P.R., and Dake M.D. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat. Med. 7 (2001) 425-429
54. Dulak J., Jozkowicz A., Frick M., Alber H.F., Dichtl W., Schwarzacher S.P., Pachinger O., and Weidinger F. Vascular endothelial growth factor: angiogenesis, atherogenesis or both?. J. Am. Coll. Cardiol. 38 (2001) 2137-2138